Viridian Therapeutics, Inc.\DE
Ticker: 1590750
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.14-99.8% | 70.57+88112.5% | 0.08+14.3% | 0.07-22.2% | 0.09+28.6% | 0.07+0.0% | 0.07+0.0% | 0.07 |
| Total Income | 0.14-99.8% | 70.57+88112.5% | 0.08+14.3% | 0.07-22.2% | 0.09+28.6% | 0.07+0.0% | 0.07+0.0% | 0.07 |
| EXPENSES | ||||||||
| Expenditure | 116.31+5.2% | 110.58+3.5% | 106.84+13.7% | 93.94+12.4% | 83.57+15.7% | 72.26+29.1% | 55.97+9.1% | 51.30 |
| PROFIT | ||||||||
| Net Profit | -104.90-203.2% | -34.60+65.7% | -100.74-15.9% | -86.91-13.3% | -76.69-18.0% | -64.99-33.9% | -48.54-1.8% | -47.66 |
| KEY METRICS | ||||||||
| OPM % | -100.00%-43.30pp | -56.70%+43.30pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00%-50.97pp | -49.03%+50.97pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | — | — | — | — | -1.15-12.7% | -1.02-29.1% | -0.79+27.5% | -1.09 |
Corporate Events
Board MeetingVRDN
20262Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect Class II direct…
SEC Filing ↗